Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells.
about
DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistanceRole of non-genomic androgen signalling in suppressing proliferation of fibroblasts and fibrosarcoma cellsNon-genomic androgen action regulates proliferative/migratory signaling in stromal cells.DYRK1B blocks canonical and promotes non-canonical Hedgehog signaling through activation of the mTOR/AKT pathway.Targeting DYRK1B suppresses the proliferation and migration of liposarcoma cells.
P2860
Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells.
@ast
Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells.
@en
Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells.
@nl
type
label
Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells.
@ast
Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells.
@en
Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells.
@nl
prefLabel
Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells.
@ast
Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells.
@en
Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells.
@nl
P2860
P1433
P1476
Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells.
@en
P2093
Eileen Friedman
Xiaobing Deng
P2860
P304
P356
10.18632/GENESANDCANCER.29
P577
2014-09-01T00:00:00Z